Ballentine Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.5M Buy
15,641
+570
+4% +$211K 0.08% 89
2026
Q1
$4.08M Sell
15,071
-1,648
-10% -$491K 0.06% 111
2025
Q4
$5.52M Buy
16,719
+550
+3% +$186K 0.08% 90
2025
Q3
$5.58M Sell
16,169
-80
-0.5% -$24.2K 0.08% 85
2025
Q2
$5.07M Sell
16,249
-1,301
-7% -$497K 0.08% 91
2025
Q1
$9.19M Buy
17,550
+448
+3% +$229K 0.16% 55
2024
Q4
$8.65M Sell
17,102
-229
-1% -$130K 0.15% 55
2024
Q3
$10.1M Buy
17,331
+809
+5% +$458K 0.17% 49
2024
Q2
$8.41M Sell
16,522
-2,981
-15% -$1.46M 0.16% 51
2024
Q1
$9.65M Sell
19,503
-229
-1% -$116K 0.18% 47
2023
Q4
$10.4M Buy
19,732
+1,378
+8% +$735K 0.21% 46
2023
Q3
$9.25M Buy
18,354
+1,139
+7% +$561K 0.22% 46
2023
Q2
$8.27M Buy
17,215
+4,277
+33% +$2.09M 0.19% 48
2023
Q1
$6.11M Sell
12,938
-2,320
-15% -$1.12M 0.15% 51
2022
Q4
$8.09M Buy
15,258
+1,624
+12% +$860K 0.24% 42
2022
Q3
$6.88M Buy
13,634
+1,536
+13% +$808K 0.24% 40
2022
Q2
$6.21M Buy
12,098
+1,000
+9% +$502K 0.22% 43
2022
Q1
$5.66M Buy
11,098
+359
+3% +$173K 0.18% 50
2021
Q4
$5.39M Buy
10,739
+1,727
+19% +$782K 0.16% 52
2021
Q3
$3.52M Buy
9,012
+36
+0.4% +$14.9K 0.12% 62
2021
Q2
$3.59M Buy
8,976
+24
+0.3% +$9.57K 0.12% 58
2021
Q1
$3.33M Sell
8,952
-133
-1% -$46.1K 0.12% 58
2020
Q4
$3.19M Sell
9,085
-1,462
-14% -$490K 0.13% 55
2020
Q3
$3.29M Sell
10,547
-939
-8% -$288K 0.15% 54
2020
Q2
$3.39M Sell
11,486
-1,889
-14% -$541K 0.16% 52
2020
Q1
$3.34M Buy
13,375
+3,241
+32% +$892K 0.19% 50
2019
Q4
$2.98M Sell
10,134
-199
-2% -$52.1K 0.14% 64
2019
Q3
$2.25M Buy
10,333
+140
+1% +$33.8K 0.11% 85
2019
Q2
$2.49M Buy
10,193
+834
+9% +$201K 0.12% 79
2019
Q1
$2.31M Buy
9,359
+209
+2% +$53.3K 0.12% 66
2018
Q4
$2.28M Buy
9,150
+53
+0.6% +$14K 0.13% 63
2018
Q3
$2.42M Buy
9,097
+59
+0.7% +$15.3K 0.13% 66
2018
Q2
$2.22M Buy
9,038
+202
+2% +$48.5K 0.12% 62
2018
Q1
$1.89M Sell
8,836
-958
-10% -$219K 0.11% 66
2017
Q4
$2.16M Sell
9,794
-1,917
-16% -$406K 0.12% 64
2017
Q3
$2.29M Buy
11,711
+237
+2% +$45.8K 0.13% 61
2017
Q2
$2.18M Buy
11,474
+1,601
+16% +$281K 0.16% 64
2017
Q1
$1.62M Buy
9,873
+3,700
+60% +$606K 0.12% 47
2016
Q4
$984K Buy
6,173
+99
+2% +$14.8K 0.08% 68
2016
Q3
$850K Buy
6,074
+430
+8% +$60.2K 0.07% 68
2016
Q2
$797K Buy
5,644
+230
+4% +$30.7K 0.07% 79
2016
Q1
$698K Buy
5,414
+750
+16% +$88.7K 0.06% 87
2015
Q4
$548K Buy
4,664
+897
+24% +$105K 0.05% 88
2015
Q3
$437K Buy
3,767
+357
+10% +$42.7K 0.05% 98
2015
Q2
$416K Buy
3,410
+32
+0.9% +$3.79K 0.04% 106
2015
Q1
$399K Buy
3,378
+536
+19% +$59.5K 0.04% 106
2014
Q4
$288K Sell
2,842
-162
-5% -$15.4K 0.03% 126
2014
Q3
$259K Buy
3,004
+313
+12% +$26.4K 0.03% 128
2014
Q2
$220K Sell
2,691
-96
-3% -$7.55K 0.03% 129
2014
Q1
$228K Buy
+2,787
New +$210K 0.03% 128

Other funds holding UNH

Ballentine Partners's UNH Position: Q2 2026 in Review

Ballentine Partners increased its UnitedHealth (UNH) stake by 3.8% in Q2 2026, buying an estimated $211K and bringing the position to 15,641 shares worth $6.5M. The position accounts for 0.08% of the portfolio, ranked #89.

Ballentine Partners first reported a position in UNH in Q1 2014 and has held it in 50 quarters since. The position peaked at $10.4M in Q4 2023. 568 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Ballentine Partners held 15,641 shares of UnitedHealth worth $6.5M as of Q2 2026.
  • Ballentine Partners bought 570 UnitedHealth shares in Q2 2026, an estimated $211K.
  • UnitedHealth made up 0.08% of Ballentine Partners's portfolio in Q2 2026, its #89 holding.
  • Ballentine Partners first reported a position in UnitedHealth in Q1 2014 and has held it in 50 quarters since.
  • Ballentine Partners's UnitedHealth position peaked at $10.4M in Q4 2023.
  • 568 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.